688166 博瑞医药
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额98,955245,559194,765311,259176,075
投资活动产生之现金流量净额(552,569)(440,142)(439,854)(871,576)(889,838)
筹资活动产生之现金流量净额293,666(24,475)61,6111,364,686703,722
汇率变动对现金及现金等价物的影响6,0632,1182,78314,1513,722
现金及现金等价物净增加/(减少)(153,886)(216,939)(180,694)818,520(6,319)
期初现金及现金等价物余额754,102971,0411,151,735333,215339,534
期末现金及现金等价物余额600,216754,102971,0411,151,735333,215